TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
MBOT

Microbot Medical Inc

Healthcare · Medical Instruments & Supplies

1.10$ +4.8% vs. previous close Closing price · As of: Nov 3, 2026

Ownership

Ownership Structure

Who owns Microbot Medical Inc (MBOT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 100.0% of the shares are freely tradable; institutional investors hold 21.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 21.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 100.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 67Mio.

Largest Shareholders

Institutions

Institutions MBOT
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 4.33 2,906,810 -0.1 06/30/2026
Mitsubishi UFJ Asset Management Co.,Ltd 1.89 1,268,453 +0.0 06/30/2026
BlackRock Inc 1.34 902,411 +5.3 06/30/2026
Geode Capital Management, LLC 1.25 836,271 +9.9 06/30/2026
UBS Group AG 1.20 806,847 -1.2 06/30/2026
DnB NOR Asset Management (Asia) 1.01 677,498 +0.0 06/30/2026
Stifel Financial Corp 0.88 589,924 +2.9 06/30/2026
Marshall Wace Asset Management Ltd 0.81 541,963 +12.7 06/30/2026

Funds

Funds MBOT
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.14 2,109,889 +0.0 09/30/2026
DNB Fund Disrpt Opps A EUR Acc 1.01 677,498 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?